Literature DB >> 21341991

L3MBTL1 deficiency directs the differentiation of human embryonic stem cells toward trophectoderm.

Ruben Hoya-Arias1, Mark Tomishima, Fabiana Perna, Francesca Voza, Stephen D Nimer.   

Abstract

Human embryonic stem cells (hESCs) can be used to study the early events in human development and, hopefully, to understand how to differentiate human pluripotent cells for clinical use. To define how L3MBTL1, a chromatin-associated polycomb group protein with transcriptional repressive activities, regulates early events in embryonic cell differentiation, we created hESC lines that constitutively express shRNAs directed against L3MBTL1. The L3MBTL1 knockdown (KD) hESCs maintained normal morphology, proliferation, cell cycle kinetics, cell surface markers, and karyotype after 40 passages. However, under conditions that promote spontaneous differentiation, the L3MBTL1 KD cells differentiated into a relatively homogeneous population of large, flat trophoblast-like cells, unlike the multilineage differentiation seen with the control cells. The differentiated L3MBTL1 KD cells expressed numerous trophoblast markers and secreted placental hormones. Although the L3MBTL1 KD cells could be induced to differentiate into various embryonic lineages, they adopted an exclusive trophoblast fate during spontaneous differentiation. Our data demonstrate that depletion of L3MBTL1 does not affect hESC self-renewal, rather it enhances differentiation toward extra-embryonic trophoblast tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21341991      PMCID: PMC3202892          DOI: 10.1089/scd.2010.0437

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  42 in total

Review 1.  Determinants of trophoblast lineage and cell subtype specification in the mouse placenta.

Authors:  David G Simmons; James C Cross
Journal:  Dev Biol       Date:  2005-08-01       Impact factor: 3.582

2.  The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms.

Authors:  I C Scott; L Anson-Cartwright; P Riley; D Reda; J C Cross
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Eomesodermin is required for mouse trophoblast development and mesoderm formation.

Authors:  A P Russ; S Wattler; W H Colledge; S A Aparicio; M B Carlton; J J Pearce; S C Barton; M A Surani; K Ryan; M C Nehls; V Wilson; M J Evans
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

4.  BMP4 initiates human embryonic stem cell differentiation to trophoblast.

Authors:  Ren-He Xu; Xin Chen; Dong S Li; Rui Li; Gregory C Addicks; Clay Glennon; Thomas P Zwaka; James A Thomson
Journal:  Nat Biotechnol       Date:  2002-11-11       Impact factor: 54.908

5.  The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).

Authors:  Piernicola Boccuni; Donal MacGrogan; Joseph M Scandura; Stephen D Nimer
Journal:  J Biol Chem       Date:  2003-02-14       Impact factor: 5.157

6.  L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.

Authors:  Nadia Gurvich; Fabiana Perna; Andrea Farina; Francesca Voza; Silvia Menendez; Jerard Hurwitz; Stephen D Nimer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

7.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis.

Authors:  S Mi; X Lee; X Li; G M Veldman; H Finnerty; L Racie; E LaVallie; X Y Tang; P Edouard; S Howes; J C Keith; J M McCoy
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

8.  Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.

Authors:  A H Peters; D O'Carroll; H Scherthan; K Mechtler; S Sauer; C Schöfer; K Weipoltshammer; M Pagani; M Lachner; A Kohlmaier; S Opravil; M Doyle; M Sibilia; T Jenuwein
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

9.  Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development.

Authors:  Heidi J Auman; Timothy Nottoli; Olga Lakiza; Quinton Winger; Stephanie Donaldson; Trevor Williams
Journal:  Development       Date:  2002-06       Impact factor: 6.868

10.  Keratin 8 protection of placental barrier function.

Authors:  Daniel Jaquemar; Sergey Kupriyanov; Miriam Wankell; Jacqueline Avis; Kurt Benirschke; Hélène Baribault; Robert G Oshima
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

View more
  4 in total

1.  Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts.

Authors:  Prasenjit Sarkar; Shan M Randall; Timothy S Collier; Anthony Nero; Teal A Russell; David C Muddiman; Balaji M Rao
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

2.  The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells.

Authors:  Fabiana Perna; Ly P Vu; Maria Themeli; Sonja Kriks; Ruben Hoya-Arias; Raya Khanin; Todd Hricik; Jorge Mansilla-Soto; Eirini P Papapetrou; Ross L Levine; Lorenz Studer; Michel Sadelain; Stephen D Nimer
Journal:  Stem Cell Reports       Date:  2015-03-05       Impact factor: 7.765

3.  Cognition and mood-related behaviors in L3mbtl1 null mutant mice.

Authors:  Erica Y Shen; Yan Jiang; Wenjie Mao; Kensuke Futai; Hanno Hock; Schahram Akbarian
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

4.  Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells.

Authors:  Yuchen Qi; Xin-Jun Zhang; Nicolas Renier; Zhuhao Wu; Talia Atkin; Ziyi Sun; M Zeeshan Ozair; Jason Tchieu; Bastian Zimmer; Faranak Fattahi; Yosif Ganat; Ricardo Azevedo; Nadja Zeltner; Ali H Brivanlou; Maria Karayiorgou; Joseph Gogos; Mark Tomishima; Marc Tessier-Lavigne; Song-Hai Shi; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2017-01-23       Impact factor: 54.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.